Highlights Novo Nordisk A/S

Equities

NOVO B

DK0062498333

Pharmaceuticals

Market Closed - Nasdaq Copenhagen Other stock markets 19:20:00 18/02/2026 +03			5-day change	1st Jan Change
311.30 ^DKK	+0.45%		+1.50%	-4.29%

02-18	Lurpak-maker Arla sees lower dairy prices and boost from protein products	RE
02-18	NOVO NORDISK : Barclays remains Neutral	ZD

Highlights

02-18	Lurpak-maker Arla sees lower dairy prices and boost from protein products	RE
02-18	Health Care Down as Deal Activity Offsets Mixed Earnings -- Health Care Roundup	DJ
02-17	Dr. Reddy's Looks to Launch Generic Wegovy at 60% Discount	MT
02-17	Dr. Reddy's Looks to Launch Generic Wegovy at 60% Discount, Reuters Reports	MT
02-17	Novo Nordisk Gets European Commission Approval for Higher-Dose Wegovy Injectable	MT
02-17	Novo Nordisk Gets European Commission Approval for Higher-Dose Wegovy Injectable	MT
02-17	Novo Nordisk Wins EU Approval for Higher Dose of Weight-loss Drug Wegovy	MT
02-17	European Commission approves more effective dose of Novo Nordisk's injectable Wegovy for adults	RE
02-17	The European Commission Approves More Effective Dose of Injectable Wegovy® for Adults with Obesity; Clinical Study Showed People Lost About 21% of Their Body Weight on Average	CI
02-17	AlphaValue/Baader Europe Lifts Sandoz Price Target, Notes Biosimilar Momentum	MT
02-17	Camurus Appoints Jane Buus Laursen as Chief Corporate Development Officer, Effective March 23, 2026	CI
02-13	Hedge funds bet big against Hims & Hers Health before Wegovy showdown, Hazeltree data shows	RE
02-13	Hedge funds bet big against Hims & Hers Health before Wegovy showdown, Hazeltree data shows	RE
02-13	US could take action including fines against Hims after brief Wegovy copy launch	RE
02-13	Novo Nordisk Estimates Updated as Berenberg Notes 'Cautious' FY26 Guidance; Price Target Down	MT
02-13	AlphaValue/Baader Europe Cuts Novo Nordisk Price Target, Forecasts Amid Outlook Downgrades, Competitive Pressures	MT
02-13	Eli Lilly builds $1.5 billion stockpile of weight-loss pill ahead of FDA decision	RE
02-12	Eli Lilly builds $1.5 billion stockpile of weight-loss pill ahead of FDA decision	RE
02-12	West Pharma forecasts 2026 profit above estimates on strong demand for drug components	RE
02-12	West Pharma forecasts 2026 profit above estimates on strong demand for drug components	RE
02-12	Earnings or Else
02-12	West Pharma forecasts 2026 profit above estimates on strong demand for drug components	RE
02-12	Results that leave no room for error
02-10	Global markets live: Alphabet, Instagram, Target, CVS Health, Coca-Cola…
02-10	Retail Hits the Brakes